Information:
Fel:
ID
33911
Beskrivning
Sunphenon in Progressive Forms of Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT00799890
Länk
https://clinicaltrials.gov/show/NCT00799890
Nyckelord
Versioner (1)
- 2019-01-07 2019-01-07 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
7 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Multiple Sclerosis NCT00799890
Eligibility Multiple Sclerosis NCT00799890
- StudyEvent: Eligibility
Similar models
Eligibility Multiple Sclerosis NCT00799890
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Primary Progressive Multiple Sclerosis chronic | Secondary Progressive Multiple Sclerosis chronic
Item
primary or secondary chronic progressive multiple sclerosis (ms)
boolean
C0751964 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
C0751965 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
C0205191 (UMLS CUI [1,2])
C0751965 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
EDSS
Item
edss 3-8
boolean
C0451246 (UMLS CUI [1])
Age
Item
age 18-65
boolean
C0001779 (UMLS CUI [1])
Multiple Sclerosis, Relapsing-Remitting
Item
relapsing-remitting ms
boolean
C0751967 (UMLS CUI [1])
Immunomodulation | Therapeutic immunosuppression
Item
immunodulatoric or immunosuppressive therapy
boolean
C1963758 (UMLS CUI [1])
C0021079 (UMLS CUI [2])
C0021079 (UMLS CUI [2])
Pretreatment Mitoxantrone | Pretreatment Natalizumab | Pretreatment Rituximab | Pretreatment Azathioprine
Item
pretreatment with mitoxantron, natalizumab, rituximab, azathioprin <2 month before screening
boolean
C3539076 (UMLS CUI [1,1])
C0026259 (UMLS CUI [1,2])
C3539076 (UMLS CUI [2,1])
C1172734 (UMLS CUI [2,2])
C3539076 (UMLS CUI [3,1])
C0393022 (UMLS CUI [3,2])
C3539076 (UMLS CUI [4,1])
C0004482 (UMLS CUI [4,2])
C0026259 (UMLS CUI [1,2])
C3539076 (UMLS CUI [2,1])
C1172734 (UMLS CUI [2,2])
C3539076 (UMLS CUI [3,1])
C0393022 (UMLS CUI [3,2])
C3539076 (UMLS CUI [4,1])
C0004482 (UMLS CUI [4,2])
Pretreatment Glatiramer acetate | Pretreatment Interferon-beta
Item
pretreatment with glairameracetat or beta-interferons <4 weeks before screening
boolean
C3539076 (UMLS CUI [1,1])
C0289884 (UMLS CUI [1,2])
C3539076 (UMLS CUI [2,1])
C0015980 (UMLS CUI [2,2])
C0289884 (UMLS CUI [1,2])
C3539076 (UMLS CUI [2,1])
C0015980 (UMLS CUI [2,2])
Signs Liver Dysfunction
Item
signs of hepatic dysfunction
boolean
C0311392 (UMLS CUI [1,1])
C0086565 (UMLS CUI [1,2])
C0086565 (UMLS CUI [1,2])
Gastric ulcer | Duodenal Ulcer
Item
active ulcus ventriculi or duodeni
boolean
C0038358 (UMLS CUI [1])
C0013295 (UMLS CUI [2])
C0013295 (UMLS CUI [2])
Neoplasms | Cure of disease Lacking Duration
Item
neoplasias if not cured >1 year before screening
boolean
C0027651 (UMLS CUI [1])
C0679252 (UMLS CUI [2,1])
C0332268 (UMLS CUI [2,2])
C0449238 (UMLS CUI [2,3])
C0679252 (UMLS CUI [2,1])
C0332268 (UMLS CUI [2,2])
C0449238 (UMLS CUI [2,3])